Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.54, $0.11 better than the analyst estimate of $0.43. Revenue for the quarter came in at $150.32 million versus the consensus estimate of $144.56 million.

GUIDANCE:

Veracyte sees FY2026 revenue of $590-596 million, versus the consensus of $585.5 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.